Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:NUVA

NuVasive (NUVA) Stock Price, News & Analysis

NuVasive logo

About NuVasive Stock (NASDAQ:NUVA)

Advanced Chart

Key Stats

Today's Range
$39.75
$39.75
50-Day Range
$38.12
$40.66
52-Week Range
$35.17
$49.53
Volume
N/A
Average Volume
1.16 million shs
Market Capitalization
$2.08 billion
P/E Ratio
79.50
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive NUVA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NuVasive and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

NUVA Stock News Headlines

BREAKING: The House just passed 3 pro-crypto bills!
THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. tc pixel
Globus Medical: Some Caution After Its Deal For Nevro
Globus acquisition of Nevro complicates story, says Stifel
See More Headlines

NUVA Stock Analysis - Frequently Asked Questions

NuVasive, Inc. (NASDAQ:NUVA) released its quarterly earnings data on Wednesday, August, 2nd. The medical device company reported $0.56 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.56. NuVasive's quarterly revenue was up 2.4% on a year-over-year basis.
Read the conference call transcript
.

The following companies are subsidiaries of NuVasive: Simplify Medical, SafePassage, Vertera Spine, Biotronic NeuroNetwork, Ellipse Technologies, NuVasive Clinical Services Monitoring Inc., NuVasive Japan KK, NuVasive Specialized Orthopedics Inc., and NuVasive Technology International Limited.

Based on aggregate information from My MarketBeat watchlists, some other companies that NuVasive investors own include Meta Platforms (META), Tesla (TSLA), NVIDIA (NVDA), First Solar (FSLR), Netflix (NFLX), Advanced Micro Devices (AMD) and Home Depot (HD).

Company Calendar

Last Earnings
8/02/2023
Today
8/27/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medical Devices
Sub-Industry
Health Care Equipment
Current Symbol
NASDAQ:NUVA
CIK
1142596
Employees
3,000
Year Founded
1997

Profitability

EPS (Trailing Twelve Months)
$0.50
Trailing P/E Ratio
79.50
Forward P/E Ratio
17.91
P/E Growth
N/A
Net Income
$40.41 million
Net Margins
2.32%
Pretax Margin
3.41%
Return on Equity
12.17%
Return on Assets
4.88%

Debt

Debt-to-Equity Ratio
0.50
Current Ratio
1.25
Quick Ratio
0.65

Sales & Book Value

Annual Sales
$1.23 billion
Price / Sales
1.70
Cash Flow
$4.96 per share
Price / Cash Flow
8.01
Book Value
$17.02 per share
Price / Book
2.34

Miscellaneous

Outstanding Shares
52,449,000
Free Float
52,171,000
Market Cap
$2.08 billion
Optionable
Optionable
Beta
1.07

Social Links

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NASDAQ:NUVA) was last updated on 8/27/2025 by MarketBeat.com Staff
From Our Partners